Understanding Snoring & Sleep Apnea
A patient-friendly primer on Obstructive Sleep Apnea (OSA) — from warning signs and risk factors to complications and the full range of treatment options, based on current clinical guidelines.
Start Here
Snoring vs. OSA — what's the difference?
Snoring
Snoring
The sound made when air passes through a narrowed upper airway, causing surrounding tissues to vibrate. Many people who snore don't have OSA — but loud, habitual snoring is one of the cardinal signs of OSA.
OSA
Obstructive Sleep Apnea
A condition in which the upper-airway muscles relax during sleep, causing the airway to collapse. Airflow becomes reduced (hypopnea) or stops entirely (apnea), producing drops in blood oxygen and forcing the brain to wake briefly so breathing can resume.
In Thailand, OSA prevalence is approximately 15.4% in men and 6.3% in women based on general-population studies.
Symptoms
Warning signs to watch for
If you or someone close to you notices any of these, it's worth speaking with the doctor to assess your OSA risk.
🔊
Habitual loud snoring
Snoring louder than normal conversation, audible through a closed door, or disturbing your sleep partner.
💨
Witnessed apnea
A partner, family member, or roommate observes you stop breathing or gasp during sleep.
😮💨
Gasping or choking awake
Waking suddenly short of breath, choking on air, or with night sweats.
😴
Daytime sleepiness
Falling asleep watching TV, in meetings, or while driving — despite a full night's sleep.
😪
Unrefreshing sleep
Waking unrefreshed with morning fatigue, headaches, or poor concentration.
🛏️
Restless sleep
Tossing, turning, fragmented sleep, or the sense that you never sleep deeply.
Who's at Risk
OSA risk factors
Risk can be assessed from medical history, physical exam, or the STOP-Bang questionnaire.
Baseline risk factors
- Male (higher risk than female)
- Age over 50
- Elevated BMI
- Neck circumference > 40 cm (16 in)
- Small chin or malocclusion
- Enlarged tonsils or long uvula
- Abnormal craniofacial structure
- Family history of OSA
Comorbidities that raise OSA risk
If you have any of the following, OSA evaluation is worth pursuing even with a low STOP-Bang score:
- Heart failure
- Coronary artery disease
- Cardiac arrhythmia
- Resistant hypertension
- Pulmonary hypertension
- Morbid obesity
- Refractory asthma
- Stroke (cerebrovascular disease)
- Acute or chronic kidney disease
- Diabetes mellitus
- Depression
- Hypothyroidism
High-stakes occupations
For public safety, OSA screening is recommended for: pilots · commercial / fuel-truck drivers · operators of complex or high-risk machinery — even when no symptoms are reported.
Why Treat
Complications of untreated OSA
Long-term untreated OSA materially affects your health and longevity.
❤️
Heart disease
Coronary artery disease and arrhythmias such as atrial fibrillation.
🩺
High blood pressure
Especially drug-resistant hypertension, plus pulmonary hypertension.
🧠
Stroke
Elevated risk of cerebrovascular events, with long-term impact on function.
🚗
Drowsy-driving crashes
Daytime sleepiness raises the risk of motor-vehicle and workplace accidents.
💔
Reduced quality of life
Affects focus, mood, relationships, and work performance.
⚠️
Other complications
Worsens diabetes, depression, kidney disease, and obesity.
Diagnosis
How is OSA diagnosed?
OSA is diagnosed via a sleep study, which measures the AHI (Apnea-Hypopnea Index) — the number of breathing pauses or shallow-breathing events per hour. Severity is graded as:
AHI 5–15
Mild
AHI 15–30
Moderate
AHI > 30
Severe
Sleep studies come in four types by equipment complexity: Type 1 (attended in-lab PSG in a hospital), Type 2 (full-channel PSG outside the lab), Type 3 (home test with at least 4 channels, used to diagnose moderate-to-severe OSA) and Type 4 (finger oximetry, screening only). Soma Wellness Prime offers a Type 3 home sleep test for ฿2,900, interpreted by a physician at Ittichai Clinic — or start with the STOP-Bang questionnaire.
Treatment Options
OSA can be treated many ways
The doctor selects the right approach based on disease severity, patient preferences, and individual anatomy — a comprehensive multidimensional evaluation.
1
Lifestyle Modification
Sleep hygiene education and weight loss. Structured follow-up substantially outperforms generic advice.
Suitable for: All patients — the foundation of any treatment plan.
2
PAP Therapy — Positive Airway Pressure
Includes CPAP (continuous), APAP (auto-adjusting), BiPAP (bi-level), and ASV — acting as a "pneumatic splint" to keep the airway open. High efficacy, low risk.
Suitable for: AHI ≥ 15, marked daytime sleepiness, elevated BMI, or significant comorbidities — the recommended first-line therapy. After a Type 3 study with Soma Wellness Prime, a CPAP trial can start right away (฿25,000 deposit · ฿2,000/week).
3
Oral Appliance
The most common is a Mandibular Advancement Device (MAD), which advances the lower jaw to open the airway. Custom-fitted by a dentist with periodic adjustments.
Suitable for: Mild-to-moderate OSA, or patients who can't tolerate PAP (e.g., frequent travellers).
4
Minimally Invasive Procedures
Radiofrequency (RF) on the nose, soft palate, or tongue base, and Erbium YAG laser for snoring and mild OSA.
Suitable for: Snoring with low OSA risk, or mild OSA. CO₂ laser LAUP is not recommended due to low success rates and high complication rates.
5
Surgical Procedures
Several types, depending on the level of obstruction:
- Nasal surgery — for nasal congestion or CPAP intolerance
- Tonsillectomy — for enlarged tonsils
- UPPP (Uvulopalatopharyngoplasty) — palate / oropharynx obstruction
- Tongue-base / hypopharyngeal / supraglottic surgery
- Skeletal surgery (MMA) — maxillomandibular advancement
- Bariatric surgery — for BMI ≥ 37.5, or ≥ 32.5 with comorbidities
- Hypoglossal nerve stimulation — an implanted device that keeps the tongue from blocking the airway during sleep, for moderate-to-severe OSA in people who cannot use CPAP (US FDA criteria: AHI 15–100, BMI up to 40), after drug-induced sleep endoscopy (DISE). Approved by the Thai FDA and offered at some Thai hospitals.
Suitable for: Patients declining PAP, younger patients, BMI < 40, or with a clear anatomic obstruction.
6
Other Alternatives
- Positional therapy — for position-dependent OSA (POSA)
- Myofunctional therapy — for snoring or mild OSA
- Decongestant medications — to improve PAP tolerance
- Tirzepatide — approved by the US FDA (Dec 2024) as the first drug for moderate-to-severe OSA in adults with obesity; in Thailand it is approved for weight management when a condition such as OSA is present. Prescription and medical supervision required.
- Wake-promoting medication — for residual sleepiness despite regular PAP use, at the doctor's discretion
- Airway-muscle pill (AD109) — under US FDA review; not yet available
- Nocturnal oxygen supplementation — adjunct to PAP in COPD or heart failure
7
Multimodality Treatment
Combining multiple approaches for better outcomes. Useful when single-modality treatment doesn't meet expectations.
FAQ
Common questions about snoring and OSA
Does everyone who snores have obstructive sleep apnea (OSA)?
No. Many people snore without OSA. But loud, habitual snoring together with witnessed pauses in breathing or marked daytime sleepiness is a key warning sign that a sleep study is worthwhile.
What AHI counts as OSA?
AHI is the number of breathing pauses or shallow-breathing events per hour of sleep. 5–15 is mild, 15–30 moderate and above 30 severe. The doctor interprets it together with your symptoms and other conditions.
Can OSA be cured? Do I need CPAP for life?
CPAP controls OSA very well when used every night, but it does not cure it. For some people, weight loss, surgery for a specific obstruction or other treatments reduce severity enough for the doctor to change the plan. Re-testing is done as the doctor advises.
Is there a medicine for OSA yet?
In December 2024 the US FDA approved tirzepatide as the first drug for moderate-to-severe OSA in adults with obesity. In Thailand, Mounjaro (tirzepatide) has been available since late May 2025, approved for type 2 diabetes and for weight management in people with a weight-related condition such as OSA; it must be prescribed and supervised by a doctor. An oral pill, AD109, is under US FDA review, with a decision due by February 2027.
What if I can't tolerate CPAP?
Options depend on severity and airway anatomy: oral appliances (MAD), positional therapy, surgery, and hypoglossal nerve stimulation — an implanted device approved by the Thai FDA and now offered at some Thai hospitals.
How dangerous is untreated OSA?
Untreated OSA raises the risk of high blood pressure, heart disease, arrhythmia, stroke, poorly controlled diabetes and drowsy-driving accidents.
References
- 2025 Thai Clinical Practice Guideline for Snoring and Obstructive Sleep Apnea in Adults — Thai Sleep Apnea Society with the Royal College of Otolaryngologists of Thailand
- US FDA: FDA Approves First Medication for Obstructive Sleep Apnea (20 Dec 2024)
- Zuellig Pharma: Mounjaro (tirzepatide) launched in Thailand, end of May 2025
- Apnimed: US FDA accepts New Drug Application for AD109 (14 Jul 2026)
- Bumrungrad International Hospital: Q&A on Hypoglossal Nerve Stimulation (Aug 2025)
- AASM Manual for the Scoring of Sleep and Associated Events
Content last reviewed: September 2026
Go Deeper
The airway is only one of three dimensions
This page covers the body — your airway. But people can test "normal" for OSA and still feel exhausted, because two other dimensions shape your sleep: your bedroom environment and your blood biochemistry. Our companion guide covers both, plus why sleep is the foundation of health — with the evidence laid out honestly.
Start by knowing your own risk
Take the 1-minute STOP-Bang questionnaire to get a personalised recommendation on whether to pursue a Sleep Study.
Take the OSA Screening Quiz